Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis
Diabetes Metab Syndr
.
2021 Mar-Apr;15(2):639-641.
doi: 10.1016/j.dsx.2021.02.021.
Epub 2021 Feb 24.
Authors
Sujan K Dhar
1
,
Kartik Sachdeva
2
,
Manjula Das
3
Affiliations
1
Beyond Antibody, InCite Lab, MSMF, 8th Floor MSMC, Bommasandra, Bangalore, India.
2
Mazumdar Shaw Medical Foundation, 8th Floor MSMC, Bommasandra, Bangalore, India.
3
Mazumdar Shaw Medical Foundation, 8th Floor MSMC, Bommasandra, Bangalore, India. Electronic address: manjula.msmf@gmail.com.
PMID:
33676871
PMCID:
PMC7903900
DOI:
10.1016/j.dsx.2021.02.021
No abstract available
Keywords:
COVID-19; Diabetes; Hypercoagulopathy; Inflammation; Meta-analysis.
Publication types
Letter
Comment
MeSH terms
COVID-19*
Diabetes Mellitus*
Humans
Inflammation
Risk Factors
SARS-CoV-2